152
Views
18
CrossRef citations to date
0
Altmetric
Original

ACTIGRAPHIC EVIDENCE FOR NIGHT-TIME HYPERKINESIA IN PARKINSON’S DISEASE

&
Pages 291-310 | Received 20 May 2007, Published online: 24 Aug 2009

REFERENCES

  • Abbott R. D., Ross G. W., White L. R., Tanner C. M., Masaki K. H., Nelson J. S., Curb J. D., Petrovitch H. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005; 65(9)1442–1446
  • Ancoli-Israel S., Cole R., Alessi C., Chambers M., Moorcroft W., Pollak C. P. The role of actigraphy in the study of sleep and circadian rhythms. Review. Sleep 2003; 26(3)342–392
  • Antonini A., Landi A., Mariani C., DeNotaris R., Pezzoli G. Deep brain stimulation and its effect on sleep in Parkinson's disease. Sleep Medicine 2004; 5(2)211–214
  • April R. S. Observations on parkinsonian tremor in all-night sleep. Neurology 1966; 16(7)720–724
  • Askenasy J. J., Yahr M. D. Different laws govern motor activity in sleep than in wakefulness. Journal of Neural Transm Gen Sect 1990a; 79: 1–2; 103–111
  • Askenasy J. J., Yahr M. D. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. Journal of Neurology and Neurosurgical Psychiatry 1990b; 53(9)749
  • Askenasy J. J. Sleep in Parkinson's disease. Acta Neurologica Scandinavica 1993; 87(3)167–170
  • Askenasy J. J. Approaching disturbed sleep in late Parkinson's Disease: First step toward a proposal for a revised UPDRS. Parkinsonism and Related Disorders 2001; 8(2)123–131
  • Askenasy J. J. Sleep disturbances in Parkinsonism. Journal of Neural Transmission 2003; 110(2)125–150
  • Bares M., Kanovsky P., Rektor I. Excessive daytime sleepiness and ‘sleep attacks’ induced by entacapone. Fundam Clinical Pharmacology 2003; 17(1)113–116
  • Braak H., Braak E. Pathoanatomy of Parkinson's disease. Journal of Neurology 2000; 247(Suppl. 2)II3–10
  • Braak H., Del Tredici K., Bratzke H., Hamm-Clement J., Sandmann-Keil D., Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). Review III/. Journal of Neurology 2002; 249(Suppl 3)1–5
  • Bracco F., Battaglia, A., Chouza C, Dupont E, Gershanik O, Marti Masso J., Montastruc J. L., PKDS009 Study Group. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: Final results of a 5-year, double-blind, levodopa-controlled study. CNS Drugs 2004; 18(11)733–746
  • Brodsky M. A., Godbold J., Roth T, Olanow C. W. Sleepiness in Parkinson's disease: A controlled study. Movement Disorders 2003; 18(6)668–672
  • Comella C. L. Sleep disturbances and excessive daytime sleepiness in Parkinson disease: An overview. Journal of Neural Transmission 2006; 70(Supplementum)349–355
  • Comella C. L., Morrissey M., Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy. Neurology 2005; 64(8)1450–1451
  • Dhawan V., Dhoat S., Williams A. J., Dimarco A., Pal S., Forbes A., Tobias A., Martinez-Martin P., Chaudhuri K. R. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. Journal of Neurol Science 2006; 248(1–2)158–162
  • Denise P., Bocca M. L. Effects of zolpidem 10 mg, zopiclone 7.5 mg and flunitrazepam 1 mg on night-time motor activity. European Neuropsychopharmacology 2003; 13(2)111–115
  • Diederich N. J., Vaillant M., Mancuso G., Lyen P., Tiete J. Progressive sleep ‘destructuring’ in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Medicine 2005; 6(4)313–318
  • Factor S. A., McAlarney T., Sanchez-Ramos J. R., Weiner W. J. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders 1990; 5(4)280–285
  • Garcia-Borreguero D., Caminero A. B., De La Llave Y., Larrosa O., Barrio S., Granizo J. J., Pareja J. A. Decreased phasic EMG activity during rapid eye movement sleep in treatment-naive Parkinson's disease: Effects of treatment with levodopa and progression of illness. Movement Disorders 2002; 17(5)934–941
  • Garcia-Borreguero D., Larrosa O., Bravo M. Parkinson's disease and sleep. Review. Sleep Medicine Reviews 2003; 7(2)115–129
  • Gomez-Esteban J. C., Zarranz J. J., Lezcano E., Velasco F., Ciordia R., Rouco I., Losada J., Bilbao I. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease. Movement Disorders 2006; 21(7)983–988
  • Grap M. J., Borchers C. T., Munro C. L., Elswick R. K., Jr., Sessler C. N. Actigraphy in the critically ill: Correlation with activity, agitation, and sedation. American Journal of Critical Care 2005; 14(1)52–60
  • Hamani C., Neimat J., Lozano A. M. Deep brain stimulation for the treatment of Parkinson's disease. Journal of Neural Transmission 2006; 70(Supplementum)393–399
  • Happe S., Berger K., FAQT Study Investigators. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease—a prospective study. Journal of Neurology 2001; 248(12)1062–1067
  • Happe S., Klosch G., Lorenzo J., Kunz D., Penzel T., Roschke J., Himanen S. L., Gruber G., Zeitlhofer J. Perception of sleep: Subjective versus objective sleep parameters in patients with Parkinson's disease in comparison with healthy elderly controls. Sleep perception in Parkinson's disease and controls. Journal of Neurology 2005; 252(8)936–943
  • Hemmeter U. M., Hamark L., Bäcker A., Thum A., Rocamora R., Penzel T., Krieg J. C. Actography in patients with depression and schizophrenia: A pilot study on circadian rhythm and sleep in psychiatric patients. Somnologie 2002; 6: 124–132
  • Hickey M. G., Demaerschalk B. M., Caselli R. J., Parish J. M., Wingerchuk D. M. Idiopathic rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist 2007; 13(2)98–101
  • Högl B., Rothdach A., Wetter T. C., Trenkwalder C. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003; 28(10)1866–1870
  • Iranzo A., Molinuevo J. L., Santamaria J., Serradell M., Marti M. J., Valldeoriola F., Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurology 2006; 5(7)572–577
  • Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clinical Pharmacology and Therapeutics 1971; 12(2)397–406
  • Katayama S. Actigraph analysis of diurnal motor fluctuations during dopamine agonist therapy. European Neurology 2001; 46(Suppl 1)11–17
  • Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eurpean Journal of Neurology 2005; 12(3)199–207
  • Laakso M. L., Leinonen L., Lindblom N., Joutsiniemi S. L., Kaski M. Wrist actigraphy in estimation of sleep and wake in intellectually disabled subjects with motor handicaps. Sleep Medicine 2004; 5(6)541–550
  • Louden M. B., Morehead M. A., Schmidt H. S. Activation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism. The West Virginia Medical Journal 1995; 91(3)101
  • Lyons K. E., Pahwa R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. Journal of Neurosurgery 2006; 104(4)502–505
  • Mouret J. Differences in sleep in patients with Parkinson's disease. Electroencephalography and Clinical Neurophysiology 1975; 38(6)653–657
  • Paus S., Brecht H. M., Koster J., Seeger G., Klockgether T., Wullner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Movement Disorders 2003; 18(6)659–667
  • Romigi A., Stanzione P., Marciani M. G., Izzi F., Placidi F., Cervellino A., Giacomini P., Brusa L., Grossi K., Pierantozzi M. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: An open label 24-hour polysomnographic study. Journal of Neural Transmission 2006; 113(12)1909–1913
  • Sadeh A., Acebo C. The role of actigraphy in sleep medicine. Review. Sleep Medicine Reviews 2002; 6(2)113–124
  • Savitt J. M., Dawson V. L., Dawson T. M. Diagnosis and treatment of Parkinson disease: Molecules to medicine. Review. Journal of Clinical Investigation 2006; 116(7)1744–1754
  • Stanley N. Actigraphy in human psychopharmacology: A review. Human Psychopharmacology 2003; 18(1)39–49
  • Stocchi F., Barbato L., Nordera G., Berardelli A., Ruggieri S. Sleep disorders in Parkinson's disease. Journal of Neurology 1998; 245(Supplementum 1)S15–S18
  • Thorpy M. J., Adler C. H. Parkinson's disease and sleep. Review. Neurologic Clinics 2005; 23(4)1187–208
  • van Hilten B, Hoff J. I., Middelkoop H. A., van der Velde E. A., Kerkhof G. A., Wauquier A., Kamphuisen H. A., Roos R. A. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Archives in Neurology 1994; 51(9)922–928
  • Van Someren E. J. Actigraphic monitoring of movement and rest-activity rhythms in aging, Alzheimer's disease, and Parkinson's disease. IEEE Trans Rehabil Eng 1997; 5(4)394–398
  • Warms C. A., Belza B. L. Actigraphy as a measure of physical activity for wheelchair users with spinal cord injury. Nursing Research 2004; 53(2)136–143
  • Ziemssen T., Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism and Related Disorders 2007; 13(16)323–332

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.